For research and educational purposes only. Not medical advice.
GHRP-1 Reference
Educational, not medical advice reference for GHRP-1: GH Release; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
Published literature on GHRP-1 is limited to older preclinical and small-human GH-response studies. There is no modern PK/PD or outcome program comparable to GHRP-2, GHRP-6, or ipamorelin.
Regulatory and posture
- Categories
- GH Release
- Aliases
- Growth hormone releasing peptide 1, SKF-108,922
- Evidence posture
- preclinical - Older preclinical and small-human GH-response data only. Less characterized than GHRP-2, GHRP-6, or ipamorelin.
- Regulatory status
- No FDA-approved GHRP-1 drug label. FDA lists GHRP-class peptides among bulk drug substances with safety-risk concerns for compounding. GHRP-1 is less characterized than GHRP-2 or GHRP-6 and is rarely studied in modern literature.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: Laron 1993 - GH-releasing activity of GHRP-1 (synthetic heptapeptide) in children and adolescents (Acta Endocrinol)
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.